Practice Expertise
- Corporate & Commercial
- Mergers & Acquisitions
- Industry & Commerce
- Healthcare & Life Sciences
Areas of Practice
- Corporate & Commercial
- Healthcare & Life Sciences
- Industry & Commerce
- Mergers & Acquisitions
- Corporate / M&A
- Start-ups & Venture Capital View More
Profile
Lucas Maurer works as an Attorney at Law at Walder Wyss. He advises clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings.
Born in 1990, Lucas Maurer studied at the University of Basel (BLaw 2015, MLaw 2017). After completing his traineeship at a law firm in Basel, Lucas Maurer was admitted to the bar in 2019 in the canton of Basel-Stadt. He started his professional career as Legal & Compliance Counsel in the legal department of an international medical device company (2019 - 2022). During his studies he was further able to gain professional experience in the legal and in the compliance department of an international pharmaceutical company as well as in a renowned US law firm in New York.
Lucas Maurer practices in German and English. He also speaks French and has basic knowledge in Mandarin. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Born in 1990, Lucas Maurer studied at the University of Basel (BLaw 2015, MLaw 2017). After completing his traineeship at a law firm in Basel, Lucas Maurer was admitted to the bar in 2019 in the canton of Basel-Stadt. He started his professional career as Legal & Compliance Counsel in the legal department of an international medical device company (2019 - 2022). During his studies he was further able to gain professional experience in the legal and in the compliance department of an international pharmaceutical company as well as in a renowned US law firm in New York.
Lucas Maurer practices in German and English. He also speaks French and has basic knowledge in Mandarin. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.
Areas of Practice
- Corporate & Commercial
- Healthcare & Life Sciences
- Industry & Commerce
- Mergers & Acquisitions
- Corporate / M&A
- Start-ups & Venture Capital
Professional Career
Significant Accomplishments
Boehringer Ingelheim acquires veterinary therapeutic vaccines developer Saiba Animal Health
Flowit announced CHF 4m seed funding round
SixPeaks Bio AG debuts with USD 110 million in Funding
Walder Wyss berät P&I Personal & Informatik AG beim Verkauf der Mirus Software AG an Alpha VCX
Axalta Coating Systems Group acquires André Koch AG
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
CONVOTIS stärkt seine Position in der Schweiz durch die neueste Akquisition der acdalis AG, einem anerkannten Spezialisten für Managed Cloud und Infrastruktur Services.
Syz Capital und Saturnus Capital investieren in Capture Media
Zusammenschluss von SETEX und Datatex mit Elvaston
CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
Pierre Fabre Laboratories acquires Vertical Bio AG
Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG
Alentis Therapeutics Closes USD 105m Series C Funding
BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital
Versant Ventures launches Vector BioPharma with USD 30m Series A
BioVersys announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR therapies
Engimmune Therapeutics raises CHF 15.5m in Seed Financing
Versant Ventures launches Cimeio Therapeutics with USD 50m Series A
Boehringer Ingelheim acquires veterinary therapeutic vaccines developer Saiba Animal Health
Flowit announced CHF 4m seed funding round
SixPeaks Bio AG debuts with USD 110 million in Funding
Walder Wyss berät P&I Personal & Informatik AG beim Verkauf der Mirus Software AG an Alpha VCX
Axalta Coating Systems Group acquires André Koch AG
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round
CONVOTIS stärkt seine Position in der Schweiz durch die neueste Akquisition der acdalis AG, einem anerkannten Spezialisten für Managed Cloud und Infrastruktur Services.
Syz Capital und Saturnus Capital investieren in Capture Media
Zusammenschluss von SETEX und Datatex mit Elvaston
CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.
LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
Pierre Fabre Laboratories acquires Vertical Bio AG
Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG
Alentis Therapeutics Closes USD 105m Series C Funding
BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital
Versant Ventures launches Vector BioPharma with USD 30m Series A
BioVersys announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR therapies
Engimmune Therapeutics raises CHF 15.5m in Seed Financing
Versant Ventures launches Cimeio Therapeutics with USD 50m Series A
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.
